Results 231 to 240 of about 122,282 (250)

Targeting DNA Topoisomerase IIα in Retinoblastoma: Implications in EMT and Therapeutic Strategies. [PDF]

Biologics
Wei Q, Lin N, Wang L.
europepmc   +1 more source

Developmental rescue of an embryonic-lethal mutation in the retinoblastoma gene in chimeric mice.

, 1994
E.C. Robanus Maandag, Martin van der Valk, M. Vlaar, Constance A. Feltkamp, Joan M. O’Brien, M van Roon, Nathalie van der Lugt, Anton Berns, Hein te Riele   +8 more
openalex   +1 more source

Prediction of mortality in patients with retinoblastoma based on random survival forest: a retrospective cohort analysis using SEER database. [PDF]

Transl Cancer Res
Zhang Z, Li M, Guo Q, Wang X.
europepmc   +1 more source

Epidemiology of oculo-orbital tumours in Malawian children: a 10-year review of cases from tertiary hospitals. [PDF]

BMC Ophthalmol
Ogbonna GO, Chikhoza M, Kwarteng MA, Ezinne NE, Ehigbor R, Anyatonwu OP, Ogiemudia OM.   +6 more
europepmc   +1 more source

The retinoblastoma-susceptibility gene product becomes phosphorylated in multiple stages during cell cycle entry and progression.

, 1992
James A. DeCaprio, Yusuke Furukawa, Florence Ajchenbaum, J D Griffin, David M. Livingston   +4 more
openalex   +1 more source

Expression of Wnt signaling proteins LEF1, β-catenin, GSK3β, DVL1, and N-myc varies across retinoblastoma subtypes and pRb phosphorylation status. [PDF]

Sci Rep
Marković L, Bukovac A, Varošanec AM, Jakovčević A, Tomas D, Sonicki Z, Puljko B, Dumančić F, Hrašćan R, Pećina-Šlaus N.   +9 more
europepmc   +1 more source

Gene expression study in retinoblastoma patients with different anaplasias and lateralities. [PDF]

Sci Rep
Li W, Xu K, Chen F.
europepmc   +1 more source

Outcomes and Predictive Factors of I-125 Plaque Therapy for Refractory Retinoblastoma. [PDF]

J Clin Med
Yousef YA, Halawa F, Mohammad M, Al-Fahoum L, Soudi R, Mehyar M, AlJabari R, Halalsheh H, AlNawaiseh I, Jaradat I.   +9 more
europepmc   +1 more source

Intra-Arterial Melphalan Chemotherapy for Retinoblastoma in a Developing Nation: Real-World Outcomes and Prognostic Factors. [PDF]

Cancers (Basel)
Yousef YA, Mohammad M, Al-Jabari O, Halawa F, Al-Fahoum L, Halalsheh H, Khzouz J, Al-Hussaini M, Jaradat I, Mehyar M, Rejdak R, Toro MD, Haboob H, Al-Nawaiseh I.   +13 more
europepmc   +1 more source

RBBP4 downregulation increases the sensitivity of A549 and HeLa cells to cisplatin by inhibiting cyclin D1 expression. [PDF]

Clinics (Sao Paulo)
Zeng Z, Mai M, Wang D, Ouyang J, Chen Z, Zhong J, Rao J.   +6 more
europepmc   +1 more source